Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications.
Lange SE, Zheleznyak A, Studer M, O'Shannessy DJ, Lapi SE, Van Tine BA. Lange SE, et al. Among authors: o shannessy dj. Oncotarget. 2016 Mar 15;7(11):13082-92. doi: 10.18632/oncotarget.7552. Oncotarget. 2016. PMID: 26909615 Free PMC article.
Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
Kurosaki A, Hasegawa K, Kato T, Abe K, Hanaoka T, Miyara A, O'Shannessy DJ, Somers EB, Yasuda M, Sekino T, Fujiwara K. Kurosaki A, et al. Int J Cancer. 2016 Apr 15;138(8):1994-2002. doi: 10.1002/ijc.29937. Epub 2015 Dec 15. Int J Cancer. 2016. PMID: 26595060
Folate receptor-α (FOLR1) expression and function in triple negative tumors.
Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA. Necela BM, et al. PLoS One. 2015 Mar 27;10(3):e0122209. doi: 10.1371/journal.pone.0122209. eCollection 2015. PLoS One. 2015. PMID: 25816016 Free PMC article.
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients.
Christoph DC, Reyna-Asuncion B, Hassan B, Tran C, Maltzman JD, O'Shannessy DJ, Gauler TC, Wohlschlaeger J, Schuler M, Eberhardt WE, Hirsch FR. Christoph DC, et al. Clin Lung Cancer. 2014 Sep;15(5):320-30.e1-3. doi: 10.1016/j.cllc.2014.05.002. Epub 2014 Jun 3. Clin Lung Cancer. 2014. PMID: 24993594
Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
Bremer RE, Scoggin TS, Somers EB, O'Shannessy DJ, Tacha DE. Bremer RE, et al. Arch Pathol Lab Med. 2013 Dec;137(12):1747-52. doi: 10.5858/arpa.2013-0039-OA. Epub 2013 Apr 9. Arch Pathol Lab Med. 2013. PMID: 23570254
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.
Christoph DC, Asuncion BR, Hassan B, Tran C, Maltzman JD, O'Shannessy DJ, Wynes MW, Gauler TC, Wohlschlaeger J, Hoiczyk M, Schuler M, Eberhardt WE, Hirsch FR. Christoph DC, et al. J Thorac Oncol. 2013 Jan;8(1):19-30. doi: 10.1097/JTO.0b013e31827628ff. J Thorac Oncol. 2013. PMID: 23242435 Free PMC article.
Characterization of the human folate receptor alpha via novel antibody-based probes.
O'Shannessy DJ, Somers EB, Albone E, Cheng X, Park YC, Tomkowicz BE, Hamuro Y, Kohl TO, Forsyth TM, Smale R, Fu YS, Nicolaides NC. O'Shannessy DJ, et al. Oncotarget. 2011 Dec;2(12):1227-43. doi: 10.18632/oncotarget.412. Oncotarget. 2011. PMID: 22204844 Free PMC article.
Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.
O'Shannessy DJ, Yu G, Smale R, Fu YS, Singhal S, Thiel RP, Somers EB, Vachani A. O'Shannessy DJ, et al. Oncotarget. 2012 Apr;3(4):414-25. doi: 10.18632/oncotarget.489. Oncotarget. 2012. PMID: 22547449 Free PMC article.
69 results
Jump to page
Feedback